Medibio
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAMedibio Limited (MEB, formerly BioProspect Limited) is a medical technology company developing a new objective test to assist in the diagnosis of depression, other mental health disorders and chronic stress. This tests utilise circadian heart rate variability.
The technology is based on the scientific finding that circadian heart rate variability is a sensitive measure for depression and other mental health disorders and chronic stress
Contact Details
Level 4, 100 Albert Road, SOUTH MELBOURNE VIC 3205
03 9692 7222
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 1012th |  | Medibio | $964k |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Matt Mesnik, Non-Executive Director | 14 Mar 2022 |
| NEW ROLE: Stephen Mitchley, Non-Executive Director | 22 Feb 2022 |
| NEW ROLE: S Sathre, Chief Financial Officer | 25 Nov 2020 |
| NEW ROLE: R. E. Lees, | 24 Nov 2020 |
| REMUNERATION UPDATE: Chris Indermaur, Non-Executive Chair | 03 Nov 2020 |
| REMUNERATION UPDATE: Frank Prendergast, Non-Executive Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Peter Carlisle, Non-Executive Director | 03 Nov 2020 |
| REMUNERATION UPDATE: David Kaysen, Chief Executive, Managing Director | 03 Nov 2020 |
| REMUNERATION UPDATE: Michael Phelps, Non-Executive Director | 03 Nov 2020 |
